CCL5 affects the prognosis and metastasis of breast cancer through C–C motif chemokine receptor 5 (CCR5)/Treg signaling pathway, which may serve as a potential therapeutic target for immunotherapy against breast cancer. Here, CCR5 is linked to breast carcinoma.